Title: Effect of Whole-Brain Radiotherapy in Alleviating Symptoms and Improving Quality of life in Patients with Brain Metastases – A Prospective Study

Authors: Dr Jewel Joseph, Dr Mahadevan R, Dr Ajith Kumar .V.R, Dr Shehna A Khader, Dr Prema. K.R, Dr K.L.Jayakumar

 DOI: https://dx.doi.org/10.18535/jmscr/v7i11.97

Abstract

Background and Objectives: Brain metastases are a common complication of cancer, and a cause of significant patient morbidity and mortality. 20-40% of cancer patients will develop metastases to brain in the course of their illness, making them the most common intracranial neoplasm in adults. A prospective observational study was done in the Department of Radiotherapy, Government Medical College Thrissur, with the primary objective of evaluating the symptom burden of the patients with brain metastasis before and after whole brain radiotherapy.

Methods: 64 patients of radiologically proven brain metastasis who satisfied the inclusion criteria were given whole brain radiotherapy with a dose of 30 Gy in 10 fractions over 2 weeks with Cobalt-60 unit. Patients were made to fill a symptom check list comprising of 10 items before radiation and during post radiation follow up at one month.

Conclusion: External beam radiotherapy with dose of 30 Gy in 10 fractions over 2 weeks achieved good palliation in terms of symptom improvement, improvement in performance status, neurological status and quality of life, especially in patients with good performance status and neurological status at presentation.

Keywords: Brain metastasis; whole brain radiotherapy; quality of life.

References

  1. Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2005;63:37-46.
  2. Schouten LJ, Rutten J, Huveneers HA et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;94:2698 –2705.
  3. Delattre JY, Krol G, Thaler HT et al. Distribution of brain metastases. Arch Neurol 1988;45:741–744.
  4. Ewing J. Metastasis. In: Ewing J, ed. Neoplastic Diseases: A Treastise on Tumours. Philadelphia: Saunders, 1940:62–74.
  5. Chang EL, Wefel JS, MaorMHet al.Apilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 2007;60:277–283; discussion 283–284.
  6. Mehta MP, Rodrigus P, Terhaard CH et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003;21:2529 –2536.
  7. Posner JB. Management of brain metastases. Rev Neurol (Paris) 1992; 148:477.

Corresponding Author

Dr Ajithkumar.V.R.

Asst. Professor, Department of Radiation Oncology, Government Medical College Chest Hospital,

Thrissur – 680596, India